Methylation of the tumor associated genes in head and neck squamous cell carcinoma
https://doi.org/10.17650/2222-1468-2022-12-4-61-70
Abstract
Introduction. Head and neck cancer is a heterogenous group of malignant tumors of different etiologies, molecular mechanisms of which are still insufficiently studied.
Aim. Investigation of DNA methylation status of some tumor associated genes (RASSF1A, RASSF2, RASSF5, CDO1, MEST and WIF1) in patients with head and neck squamous cell carcinoma.
Materials and methods. The DNA methylation level of normal and tumor tissues was analyzed using bisulfite conversion and methylation-sensitive high-resolution melting in 25 patients (21 men and 4 women) diagnosed with neck squamous cell carcinoma.
Results. There were significant differences in levels of DNA methylation between tumor and normal tissues in the CDO1 and WIF1 genes in all groups and subgroups of patients (larynx and other cancers, squamous cell carcinoma keratinizing and non-keratinizing, primary and recurrent tumor, smokers and non-smokers). The methylation level in the CDO1 gene in tumor tissue was significantly increased in the T4 and T3 stage subgroups compared to T2.
Conclusion. The increased level of methylation of the CDO1 and WIF1 genes, as well as changes in their expression are among the molecular mechanisms involved in the neck squamous cell carcinoma development. They can be considered as prognostic and diagnostic markers for this pathology.
Supporting agencies: The study was carried out with the financial support of the Ministry of Education and Science of Russia (Agreement No. 075-15-2021-1356 dated 7.10.2021; internal agreement number 15.SIN.21.0011; identifier RF 0951.61321X0012).
About the Authors
S. V. Kurevlev
Рeoples’ Friendship University of Russia
Russian Federation
Russian Federation
6 Miklukho-Maklaya St., Moscow 117198
L. V. Tskhovrebova
Рeoples’ Friendship University of Russia
Russian Federation
Russian Federation
Leila Vakhtangovna Tskhovrebova
6 Miklukho-Maklaya St., Moscow 117198
A. V. Aghajanyan
Рeoples’ Friendship University of Russia
Russian Federation
Russian Federation
6 Miklukho-Maklaya St., Moscow 117198
T. Kh. Fatkhudinov
Рeoples’ Friendship University of Russia
Russian Federation
Russian Federation
6 Miklukho-Maklaya St., Moscow 117198
K. B. Gordon
Рeoples’ Friendship University of Russia; A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Center of Radiology, Ministry of Health of Russia
Russian Federation
Russian Federation
6 Miklukho-Maklaya St., Moscow 117198
4 Koroleva St., Obninsk 249036
M. M. Azova
Рeoples’ Friendship University of Russia
Russian Federation
Russian Federation
6 Miklukho-Maklaya St., Moscow 117198
References
1. Demokan S., Dalay N. Role of DNA methylation in head and neck cancer. Clin Epigenet 2011;2:123–50. DOI: 10.1007/s13148-011-0045-3
2. Malignant neoplasms in Russia in 2016 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. M.: P.A. Herzen Moscow State Medical Research Institute, Branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia, 2018. 250 p. (In Russ.).
3. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7. DOI: 10.3322/caac.21708
4. Marcu L.G., Yeoh E. A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. J Cancer Res Clin Oncol 2009;135(10):1303–14. DOI: 10.1007/s00432-009-0648-7
5. World Health Organization. World health report 2002: reducing risks, promoting healthy life. Available at: https://www.who.int/publications/i/item/9241562072.
6. World Health Organization. WHO global report on trends in tobacco smoking 2000–2025, 2015. Available at: https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition.
7. Global Cancer Observatory. International Agency for Research on Cancer. World Health Organization. Available at: https://gco.iarc.fr/tomorrow/en/dataviz/bubbles?types=0&sexes=1_2&mode=population&group_populations=0&multiple_populations=1&multiple_cancers=1&cancers=39&populations=903_904_905_908_909_935&apc=cat_ca20v1.5_ca23v-1.5&group_cancers=1.
8. Gupta Sh., Kumar P., Maini J. et al. Epigenetic biomarkers in head and neck cancer. J Cancer Genetics Biomark 2018. DOI: 10.14302/issn.2572-3030.jcgb-18-2428. Available at: https://www.researchgate.net/publication/329389358_Epigenetic_Biomarkers_in_Head_and_Neck_Cancer.
9. Castilho R.M., Squarize C.H., Almeida L.O. Epigenetic modifications and head and neck cancer: Implications for tumor progression and resistance to therapy. Int J Mol Sci 2017;18(7):1506. DOI: 10.3390/ijms18071506
10. Ovchinnikov D.A., Cooper M.A., Pandit P. et al. Tumor-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients. Transl Oncol 2012;5(5):321–6. DOI: 10.1593/tlo.12232
11. Liyanage C., Wathupola A., Muraleetharan S. et al. Promoter hypermethylation of tumorsuppressor genes p16INK4a, RASSF1A, TIMP3, and PCQAP/MED15 in salivary DNA as a quadruple biomarker panel for early detection of oral and oropharyngeal cancers. Biomolecules 2019;9(4):148. DOI: 10.3390/biom9040148
12. Righini C.A., de Fraipont F., Timsit J.F. et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 2007;13(4):1179–85. DOI: 10.1158/1078-0432.CCR-06-2027
13. Arantes L.M.R.B., De Carvalho A.C., Melendez M.E., Carvalho A.L. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn 2018;18(1):85–112. DOI: 10.1080/14737159.2017.1404906
14. Zhou C., Ye M., Ni S. et al. DNA methylation biomarkers for head and neck squamous cell carcinoma. Epigenetics 2018;13(4):398– 409. DOI: 10.1080/15592294.2018.1465790
15. Noorlag R., van Kempen P.M.W., Moelans C.B. et al. Promoter hypermethylation using 24-gene array in early head and neck cancer better outcome in oral than in oropharyngeal cancer. Epigenetics 2014;9(9):1220–7. DOI: 10.4161/epi.29785
16. Krasny A.M., Kurevlev S.V., Sadekova A.A. et al. The profile of methylation of primary tumor genes in patients with luminal HER2-negative breast cancer with metastasis to regional lymph nodes. Biomedicinskaya himiya = Biomedical Chemistry 2021;67(1):88–94. (In Russ.).
17. Słomka M., Sobalska-Kwapis M., Wachulec M. et al. High resolution melting (HRM) for high-throughput genotyping – limitations and caveats in practical case studies. Int J Mol Sci 2017;18(11):2316. DOI: 10.3390/ijms18112316
18. Yeh K.T., Chang J.G., Lin T.H. et al. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. Int J Oncol 2003;23(4):1001–7. DOI: 10.3892/ijo.23.4.1001
19. Brait M., Ling Sh., J. Nagpal K. et al. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS One 2012;7(9):e44951. DOI: 10.1371/journal.pone.0044951
20. Sjoblom T., Jones S., Wood L.D. et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314(5797):268–74. DOI: 10.1126/science.1133427
21. Minatani N., Waraya M., Yamashita K. et al. Prognostic significance of promoter DNA hypermethylation of cysteine dioxygenase 1 (CDO1) gene in primary breast cancer. PLoS One 2016;11(1):e0144862. DOI: 10.1371/journal.pone.0144862
22. Meller S., Zipfel L., Gevensleben H. et al. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients. Epigenetics 2016;11(12):871–80. DOI: 10.1080/15592294.2016.1241931
23. Yang T.-M., Leu S.-W., Li J.-M. et al. WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions. J Cancer Res Clin Oncol 2009;135(7):919–24. DOI: 10.1007/s00432-008-0527-7
24. Paluszczakm J., Sarbak J., Kostrzewska-Poczekaj M. et al. The negative regulators of Wnt pathway – DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival. Tumor Biol 2015;36(4):2855– 61. DOI: 10.1007/s13277-014-2913
25. Pannone G.B.P., Santoro A., Franco R. et al. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep 2010;24(4):1035–41. DOI: 10.3892/or.2010.1035
26. Supic G., Kozomara R., Jovic N. et al. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers. Oral Dis 2011;17(8):794–800. DOI: 10.1111/j.1601-0825.2011.01838
27. Takashi I., Minoru T., Suzuki H. et al. Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma. Cancer Sci 2008;99(5):958–66. DOI: 10.1111/j.1349-7006.2008.00769
28. Ogi K., Toyota M., Ohe-Toyota M. et al. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 2002;8(10):3164–71.
29. Zhang Z., Van Sun D., Do N. et al. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Int J Cancer 2007;120:32–8. DOI: 10.1002/ijc.22185
30. Lo K.W., Kwong J., Hui A.B. et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001;61(10):3877–81. DOI: 10.1080/00313020500058623
31. Strzelczyka J.K., Krakowczykb Ł., Owczarekc A.J. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma. Arc Oral Biol 2019;98:265–72. DOI: 10.1016/j.archoralbio.2018.12.001
32. Kerjean A., Dupont J.M., Vasseur C. et al. Establishment of the paternal methylation imprint of the human H19 and MEST/PEG1 genes during spermatogenesis. Hum Mol Genet 2000 ;9(14):2183–7. DOI: 10.1093/hmg/9.14.2183
33. Boot A., Oosting J., de Miranda N. et al. Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells. J Pathol 2016;240(1):72–83. DOI: 10.1002/path.4756
34. Dohi O., Yasui K., Gen Y. et al. Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma. Int J Oncol 2013;42(2):411–8. DOI: 10.3892/ijo.2012.1724
35.
Review
For citations:
Kurevlev S.V., Tskhovrebova L.V., Aghajanyan A.V., Fatkhudinov T.Kh., Gordon K.B., Azova M.M. Methylation of the tumor associated genes in head and neck squamous cell carcinoma. Head and Neck Tumors (HNT). 2022;12(4):61-70. (In Russ.) https://doi.org/10.17650/2222-1468-2022-12-4-61-70
Views:
256
Email this article 